Search Results - "Sink, K S"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety by Sink, K S, Walker, D L, Freeman, S M, Flandreau, E I, Ressler, K J, Davis, M

    Published in Molecular psychiatry (01-03-2013)
    “…The lateral division of the bed nucleus of the stria terminalis (BNST), which forms part of the circuitry regulating fear and anxiety, contains a large number…”
    Get full text
    Journal Article
  2. 2

    Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors by Sink, K.S., Chung, A., Ressler, K.J., Davis, M., Walker, D.L.

    Published in Behavioural brain research (15-04-2013)
    “…► Knockdown of CRF expression locally within the BNST disrupted BNST CGRP-enhanced startle. ► Systemic or intra-BNST CRFR1 antagonists blocked BNST…”
    Get full text
    Journal Article
  3. 3

    Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior by Sink, K. S., Vemuri, V. K., Olszewska, T., Makriyannis, A., Salamone, J. D.

    Published in Psychopharmacologia (01-03-2008)
    “…Rationale Cannabinoid CB1 antagonists/inverse agonists suppress food-motivated behaviors and are being evaluated as potential appetite suppressants. It has…”
    Get full text
    Journal Article
  4. 4

    The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats by Sink, K.S., Segovia, K.N., Collins, L.E., Markus, E.J., Vemuri, V.K., Makriyannis, A., Salamone, J.D.

    Published in Pharmacology, biochemistry and behavior (01-06-2010)
    “…The effects of CB1 antagonist/inverse agonists on the acquisition and consolidation of conditioned fear remain uncertain. Recent studies suggest that the CB1…”
    Get full text
    Journal Article
  5. 5

    Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113 by Sink, K.S., Vemuri, V.K., Wood, J., Makriyannis, A., Salamone, J.D.

    Published in Pharmacology, biochemistry and behavior (01-01-2009)
    “…Drugs that interfere with cannabinoid CB1 transmission suppress food-motivated behaviors, and may be clinically useful as appetite suppressants. Several CB1…”
    Get full text
    Journal Article
  6. 6

    Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142 by Sink, K.S, Segovia, K.N, Sink, J, Randall, P.A, Collins, L.E, Correa, M, Markus, E.J, Vemuri, V.K, Makriyannis, A, Salamone, J.D

    Published in European neuropsychopharmacology (01-02-2010)
    “…Abstract Cannabinoid CB1 inverse agonists suppress food-motivated behaviors, but may also induce psychiatric effects such as depression and anxiety. To…”
    Get full text
    Journal Article
  7. 7

    Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats by Sink, K. S., Segovia, K. N., Nunes, E. J., Collins, L. E., Vemuri, V. K., Thakur, G., Makriyannis, A., Salamone, J. D.

    Published in Psychopharmacologia (01-10-2009)
    “…Rationale Drugs that interfere with cannabinoid CB1 transmission suppress food-motivated behaviors and may be useful as appetite suppressants, but there is…”
    Get full text
    Journal Article
  8. 8

    Effects of the adenosine A2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide by Betz, A.J, Vontell, R, Valenta, J, Worden, L, Sink, K.S, Font, L, Correa, M, Sager, T.N, Salamone, J.D

    Published in Neuroscience (29-09-2009)
    “…Abstract Typical antipsychotic drugs, including haloperidol and pimozide, have been shown to produce parkinsonian motor effects such as akinesia and tremor…”
    Get full text
    Journal Article
  9. 9

    Effects of the adenosine A sub(2) sub(A) antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide by Betz, A J, Vontell, R, Valenta, J, Worden, L, Sink, K S, Font, L, Correa, M, Sager, T N, Salamone, J D

    Published in Neuroscience (29-09-2009)
    “…Typical antipsychotic drugs, including haloperidol and pimozide, have been shown to produce parkinsonian motor effects such as akinesia and tremor…”
    Get full text
    Journal Article
  10. 10

    Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide by Betz, A J, Vontell, R, Valenta, J, Worden, L, Sink, K S, Font, L, Correa, M, Sager, T N, Salamone, J D

    Published in Neuroscience (29-09-2009)
    “…Typical antipsychotic drugs, including haloperidol and pimozide, have been shown to produce parkinsonian motor effects such as akinesia and tremor…”
    Get full text
    Journal Article